SHORT HILLS, N.J.--(BUSINESS WIRE)--Bayshore Pharmaceuticals, LLC is pleased to introduce three new FDA-approved products to their expanding portfolio.
Edenbridge Pharms's Generic Etodolac Receives Approval in US
Amneal Pharms Generic Etodolac Receives Approval In US
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
IDT Australia release on FDA nod for 23 generics begs the question: Where`s the beef?
Recall of One Batch Of RAN-Gabapentin 100 Mg Capsules Due To Cross-Contamination With Etodolac